Literature DB >> 26247237

Thrombin generation in two families with MYH9-related platelet disorder.

Eva Zetterberg1, Margareta S Carlsson Alle2, Juliane Najm3, Andreas Greinacher4.   

Abstract

MYH9-related platelet disorders are inherited macrothrombocytopenias with additional clinical manifestations including renal failure, hearing loss, pre-senile cataract, and inclusion bodies in leucocytes that are present in different combinations. The MYH9 gene codes for the cytoplasmic contractile protein non-muscular myosin heavy chain IIA, present in several tissues. The bleeding tendency is usually mild to moderate but rarely, thrombotic complications are also seen. We report on the thrombin generation potential (ETP) in patients with MYH9-related disease with and without arterial thrombosis. In family A, four affected members [c.5521G>A mutation causing p.(Glu1841Lys)] were evaluated. Three of them had a moderate bleeding tendency and in two renal insufficiency and hearing loss were already present. These two patients had an arterial thrombosis (myocardial infarction and pons infarction, respectively) before 50 years of age. In family B, two members were affected [c.4679T>G, resulting in p.(Val1560Gly)]. Their bleeding tendency was mild (bleeding scores 4 and 3, respectively). Thrombelastography (ROTEM) was normal in all six individuals. ETP was below the normal range in family B. However, in family A, the two members affected by thrombosis had a normal ETP, indicating that other factors compensated for the low platelet count and might have contributed to the arterial thrombosis.

Entities:  

Keywords:  MYH-9; platelet; thrombin generation; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26247237     DOI: 10.3109/09537104.2015.1064882

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  1 in total

1.  Idiopathic Pulmonary Embolism in a case of Severe Family ANKRD26 Thrombocytopenia.

Authors:  Jerome Guison; Gilles Blaison; Oana Stoica; Remy Hurstel; Marie Favier; Remy Favier
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-06-16       Impact factor: 2.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.